Logo

Delfi Diagnostics: Jacob Van Naarden

Jun 22, 2022

Delfi Diagnostics has appointed Jacob Van Naarden to its board of directors. Van Naarden is senior VP of Eli Lilly and CEO of [email protected] He previously served as chief operating officer at Loxo Oncology, which Lilly acquired in 2019. He also previously held positions at HealthCor Management, Aisling Capital, and Goldman Sachs.

Breaking News
The Scan

ChatGPT Does As Well As Humans Answering Genetics Questions, Study Finds

Researchers in the European Journal of Human Genetics had ChatGPT answer genetics-related questions, finding it was about 68 percent accurate, but sometimes gave different answers to the same question.

Sequencing Analysis Examines Gene Regulatory Networks of Honeybee Soldier, Forager Brains

Researchers in Nature Ecology & Evolution find gene regulatory network differences between soldiers and foragers, suggesting bees can take on either role.

Analysis of Ashkenazi Jewish Cohort Uncovers New Genetic Loci Linked to Alzheimer's Disease

The study in Alzheimer's & Dementia highlighted known genes, but also novel ones with biological ties to Alzheimer's disease.

Tara Pacific Expedition Project Team Finds High Diversity Within Coral Reef Microbiome

In papers appearing in Nature Communications and elsewhere, the team reports on findings from the two-year excursion examining coral reefs.